NewAmsterdam Pharma Company NAMS Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from NewAmsterdam Pharma Company’s reported figures.
The official record: NewAmsterdam Pharma Company’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about NewAmsterdam Pharma Company's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is NewAmsterdam Pharma Company's free cash flow?
- NewAmsterdam Pharma Company (NAMS) reported free cash flow of -$30.64M in Q1 2026.
- How has NewAmsterdam Pharma Company's free cash flow changed year-over-year?
- NewAmsterdam Pharma Company's free cash flow increased by 16.0% year-over-year, from -$36.48M to -$30.64M.
- What is the long-term trend for NewAmsterdam Pharma Company's free cash flow?
- Over 4 years (2021 to 2025), NewAmsterdam Pharma Company's free cash flow has grown at a 49.6% compound annual growth rate (CAGR), from -$29.54M to -$148.03M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.